SCHEMBL8956753

SCHEMBL8956753

O=C(O)Cc1nn(C/C(F)=C\c2cccc(C(F)(F)F)c2F)c(=O)c2ccccc12

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ AKR1B1 P15121 19/20 0.60
▸ MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8956748 1.00 AKR1B1 (0.60) AKR1B1MAPT
SCHEMBL8956757 1.00 AKR1B1 (0.60) AKR1B1MAPT
SCHEMBL8956740 0.83 AKR1B1 (0.56) AKR1B1MAPT
SCHEMBL8956749 0.83 AKR1B1 (0.56) AKR1B1MAPT
SCHEMBL8956786 0.80 AKR1B1 (0.66) AKR1B1MAPT
SCHEMBL8956759 0.80 AKR1B1 (0.66) AKR1B1MAPT
SCHEMBL8956792 0.80 AKR1B1 (0.66) AKR1B1MAPT
SCHEMBL9216041 0.75 AKR1B1 (0.68) AKR1B1MAPT
SCHEMBL9327258 0.75 MAPT (0.78) AKR1B1MAPT
SCHEMBL8956849 0.73 AKR1B1 (0.52) AKR1B1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5489592-A ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETES-RELATED DISORDERS LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1996-02-06 — — US disclosed
Send feedback